Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Accumulated Expenses (2022 - 2025)

Neuraxis' Accumulated Expenses history spans 4 years, with the latest figure at $2.4 million for Q4 2025.

  • On a quarterly basis, Accumulated Expenses rose 89.74% to $2.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.4 million, a 89.74% increase, with the full-year FY2025 number at $2.4 million, up 89.74% from a year prior.
  • Accumulated Expenses hit $2.4 million in Q4 2025 for Neuraxis, up from $66648.0 in the prior quarter.
  • Over the last five years, Accumulated Expenses for NRXS hit a ceiling of $2.4 million in Q4 2025 and a floor of $26286.0 in Q2 2023.
  • Historically, Accumulated Expenses has averaged $540257.7 across 4 years, with a median of $233868.0 in 2023.
  • Biggest five-year swings in Accumulated Expenses: surged 214.47% in 2024 and later crashed 91.84% in 2025.
  • Tracing NRXS's Accumulated Expenses over 4 years: stood at $834062.0 in 2022, then plummeted by 51.91% to $401088.0 in 2023, then surged by 214.47% to $1.3 million in 2024, then soared by 89.74% to $2.4 million in 2025.
  • Business Quant data shows Accumulated Expenses for NRXS at $2.4 million in Q4 2025, $66648.0 in Q3 2025, and $66648.0 in Q2 2025.